You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
同和藥業(300636.SZ)上修業績預告:一季度淨利預增235%-265%
格隆匯 04-09 20:36

格隆匯4月9日丨同和藥業(300636.SZ)披露2020年第一季度業績預告修正公告,修正前,預計歸屬於上市公司股東的淨利潤983.51萬元-1117.63萬元,同比增長120%-150%。修正後,預計歸屬於上市公司股東的淨利潤1497.62萬元-1631.73萬元,同比增長235%-265%。

業績修正原因系報告期內,公司復工復產較順利,在拓展高端市場方面取得一定進展,市場需求旺盛,同時不斷加大研發投入、優化產品工藝,從而使公司整體效益得到提高,公司營業收入和利潤水平均超過前次預計情況。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account